Can-Fite Begins Phase II Trials for Treatment of Symptoms of Keratitis Sicca (Dry-Eye Syndrome)可以- fite開始二期試驗治療症狀性角膜炎乾燥（幹眼綜合症）
Can-Fite BioPharma Ltd. (TASE:CFBI) has begun Phase II clinical trials for its CF101 drug for the treatment of symptoms of keratitis sicca (dry-eye syndrome).可以- fite biopharma有限公司（ tase ： cfbi ）已開始二期臨床試驗，其cf101藥物用於治療症狀性角膜炎乾燥（幹眼綜合症） 。
The test will be conducted in Israel among 50 patients who will receive CF101 over 12 weeks at four medical centers.該試驗將在以色列之間的50例，這些人將得到cf101超過12個星期，在4個醫療中心。
The results of the trial will also be sent to the US Food and Drug Administration (FDA).試驗結果，也將被送往美國食品和藥物管理局（ FDA ） 。 If CF101 is shown to be effective, Can-Fite can apply for orphan drug status, which if approved, will greatly speed up its development.如果cf101證明是有效的，可以- fite可以申請罕用藥物地位，如果獲得批准，將大大加快其發展。
Dry eye syndrome commonly affects wearers of contact lenses, women going through menopause, and is a side effect of rheumatoid arthritis.幹眼綜合徵常見的影響配戴的隱形眼鏡，婦女經歷更年期，是一個具有副作用的類風濕關節炎。 Figures published indicate that the over six million people in the US alone suffer from dry eye syndrome, and the market for treatments is estimated at $1 billion a year.公佈的數字表明，有超過600萬人，僅在美國遭受幹眼綜合徵，並為市場的治療，估計在每年10億美元。
Source: Globes [online], Israel business news - www.globes.co.il - on January 28, 2007資料來源：金球獎[在線] ，以色列商業新聞-w ww.globes.co.il-對2 0 07年1月2 8日
You may also like to read您可能還喜歡讀
- Novagali eye Treatment for Vernal Keratoconjunctivitis (VKC) Successful in Phase III Trial novagali眼科治療春季角結膜炎（ vkc ）成功地在第三階段試驗
- Post-Lasik Near Vision Treatment With Conductive Keratoplasty Trial Underway LASIK術後不久的眼光對待與導電性角膜移植的審判正在進行
- Beware of Computer Vision Syndrome當心電腦視覺症候群
- Fusarium Keratitis: General Information And Awareness鐮刀菌性角膜炎：一般信息和意識
- Phase-II Clinical Trial of Drug Evizon for Wet Age-Related Macular Degeneration相II期臨床試驗的藥物evizon濕年齡相關性黃斑變性
- Phase II Clinical Trial of Mifepristone an Eye Drop Treatment for Steroid Associated Elevated Intraocular Pressure第二期臨床試驗米非司酮一種眼藥水治療類固醇相關的高眼壓
- Dry Eye Syndrome in Women May be Prevented by Regulating Fatty Acid Intake幹眼綜合徵的婦女可能被阻止通過調節脂肪酸攝入量
- Dry Eye Treatment by Omega Fatty Acids in Combination with Artificial Tears乾眼症的治療奧米加脂肪酸結合人工淚液
- Progesterone can Effectively Treat Dry Eye Syndrome黃體酮可有效治療幹眼綜合徵
- Bausch & Lomb Permanently Withdraw The Contact Lens Solution Which Found to Increase the Risk of Fusarium Keratitis博士倫永久退出接觸鏡片的解決方案，其中發現的風險增加，鐮刀菌性角膜炎
